SCHEMBL14970865

SCHEMBL14970865

Cc1cc(C)cc(NC(=O)c2cc(-c3ccccc3)nc3ccccc23)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.81
MEN1 O00255 6/20 0.73
KMT2A Q03164 6/20 0.73
PTGER4 P35408 2/20 0.70
CYP2C9 P11712 2/20 0.67
MAPT P10636 3/20 0.67
LMNA P02545 2/20 0.67
HTT P42858 2/20 0.67
ALDH1A1 P00352 2/20 0.65
CYP1A2 P05177 1/20 0.65
ALOX12 P18054 1/20 0.65
CYP2C19 P33261 1/20 0.65
KCNH2 Q12809 1/20 0.65
CA12 O43570 2/20 0.64
CA1 P00915 2/20 0.64
CA2 P00918 2/20 0.64
CA9 Q16790 2/20 0.64
GFER P55789 1/20 0.64
NPY1R P25929 1/20 0.62
RECQL P46063 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14970875 0.88 CYP3A4 (1.00) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL10061503 0.82 MAPT (0.77) CYP3A4MEN1KMT2AMAPTLMNA
SCHEMBL13912444 0.82 CYP3A4 (0.77) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL30102560 0.81 RXFP1 (0.73) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL17689194 0.81 CYP3A4 (0.77) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL24688074 0.81 RXFP1 (0.73) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL23722908 0.81 CYP3A4 (1.00) CYP3A4MEN1KMT2APTGER4CYP2C9
SCHEMBL14623959 0.81 TACR3 (0.72) CYP3A4MEN1KMT2APTGER4LMNA
SCHEMBL17689185 0.80 MEN1 (0.76) CYP3A4MEN1KMT2ACYP2C9MAPT
SCHEMBL13253446 0.80 CYP3A4 (0.66) CYP3A4MEN1KMT2APTGER4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-09-18 US disclosed
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-09-18 US disclosed
WO-2013074059-A2 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275224-A1 CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION CDA, DCTD, ADA CYP3A4 2842/4885MEN1 2244/4885KMT2A 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.